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Advanced glycation end-products (AGEs) are formed during non-enzymatic
reactions involving proteins and sugars, i.e. the Maillard or browning reaction. The
early glycation is reversible and involves the production of a Schiff base from the
carbonyl group of a reducing sugar and the primary amino groups of a protein
(lysine, arginine). The imine adduct undergoes a rearrangement yielding Amadori
products. During the late stage, complex irreversible oxidation, condensation and
cyclisation reactions lead to AGEs via intra- and intermolecular protein
crosslinkage.1
In diabetes, when the organism can no longer synthesise or properly metabolize
insulin, chronic hyperglycaemia induces increased AGE formation and
consequently vascular complications. Therefore insulin or oral antidiabetics are
used to lower blood sugar levels and to limit the formation of AGEs.1 However,
antioxidants acting by radical scavenging or metal chelation as well as compounds
capable of trapping dicarbonyl species or breaking AGEs may also reduce the
amount of AGEs and diabetic complications.2 As AGEs are also responsible for the
aging of many tissues and accumulate in organisms over time, such substances
could also be useful for limiting age-related diseases. With this in mind our
research focused on the investigation of new AGE inhibitors.
In the process we have developed a simple, cheap and high-throughput screening
(HTS) assay based on AGE fluorescence, which is highly suitable for the analysis of
NPs and extracts. The development of this assay will be presented, and in
particular its applicability for the systematic quantification of both vesperlysines
and pentosidine-like AGEs will be discussed.1,3
By now the main focus of our ongoing project is to identify promising products and
plants for future applications as cosmetics and therapeutic agents. Therefore this
assay was adapted and patented for the identification of active anti-AGE
compounds designated for cosmetic purposes. On the other hand, as anti-AGE
compounds are often able to prevent endothelial dysfunction in blood vessels, this
HTS assay is also used to select promising NPs and vegetal extracts for further
biological applications focusing on the prevention of cardiovascular events4 and
graft rejections.
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